Diabetes is one of the most common chronic conditions among Medicare beneficiaries. Insulin costs, CGM coverage, and specialist access are the key factors to evaluate in any plan.
Educational content only. This page is not medical advice. Consult your physician for medical guidance and a licensed insurance professional for coverage decisions.
Diabetes is a chronic metabolic condition in which the body either doesn't produce enough insulin (Type 1) or doesn't use insulin effectively (Type 2). Insulin is the hormone that regulates blood sugar (glucose). Without proper regulation, blood sugar levels rise, damaging blood vessels and nerves throughout the body over time.
More than 37 million Americans have diabetes, and approximately 1 in 4 Medicare beneficiaries has been diagnosed with the condition. Type 2 diabetes accounts for 90–95% of all cases.
Diabetes is a lifelong condition but is highly manageable with the right treatment. Many people with well-controlled diabetes live full, active lives. The key is consistent medication adherence, blood sugar monitoring, and regular specialist follow-up to catch complications early.
As of 2023, Medicare caps the out-of-pocket cost of covered insulin at $35 per month per prescription. This applies to all Medicare Part D plans and Medicare Advantage plans with drug coverage. If you use insulin, this is a significant benefit — but verify your specific insulin brand is on the plan's formulary.
Medication costs and supplies coverage are the top priorities for most diabetes patients evaluating plans.
Use the Medicare Plan Finder to check your specific medications on each plan's formulary — or work with an agent who can do the comparison for you.